Sign in
4

Changes in Ownership

Silexion Therapeutics Corp Filed Acc 0001178913-26-000596

Director acquired 7,576 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Peled Amnon · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-20 Grant or award : show line 1 in the form +7,576 8,237 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-20 Grant or award : show line 2 in the form Stock Option (right to buy Ordinary Shares) +8,904 8,904 D
Loading xslF345X05/zk2634424.xml…